Bartsch R - Search Results

1

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M. Dubsky PC, et al. Among authors: bartsch r. J Clin Oncol. 2012 Mar 1;30(7):722-8. doi: 10.1200/JCO.2011.36.8993. Epub 2012 Jan 23. J Clin Oncol. 2012. PMID: 22271481 Clinical Trial.

2

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study.

Wenzel C, Hussian D, Bartsch R, Pluschnig U, Locker GJ, Rudas M, Gnant MF, Jakesz R, Zielinkski CC, Steger GG. Wenzel C, et al. Among authors: bartsch r. J Cancer Res Clin Oncol. 2004 Jul;130(7):400-4. doi: 10.1007/s00432-004-0559-6. J Cancer Res Clin Oncol. 2004. PMID: 15168107 Clinical Trial.

3

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer.

Wenzel C, Bartsch R, Locker GJ, Hussian D, Pluschnig U, Sevelda U, Gnant MF, Jakesz R, Zielinski CC, Steger GG. Wenzel C, et al. Among authors: bartsch r. Anticancer Drugs. 2005 Apr;16(4):441-5. doi: 10.1097/00001813-200504000-00011. Anticancer Drugs. 2005. PMID: 15746581 Clinical Trial.

4

Preoperative second-line chemotherapy induces objective responses in primary breast cancer.

Wenzel C, Locker GJ, Bartsch R, Pluschnig U, Hussian D, Zielinski CC, Rudas M, Gnant MF, Jakesz R, Steger GG. Wenzel C, et al. Among authors: bartsch r. Wien Klin Wochenschr. 2005 Jan;117(1-2):48-52. doi: 10.1007/s00508-004-0282-y. Wien Klin Wochenschr. 2005. PMID: 15986591 Clinical Trial.

5

Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial.

Bartsch R, Wenzel C, Pluschnig U, Hussian D, Sevelda U, Locker GJ, Mader R, Zielinski CC, Steger GG. Bartsch R, et al. Cancer Chemother Pharmacol. 2006 May;57(5):554-8. doi: 10.1007/s00280-005-0092-6. Epub 2005 Aug 23. Cancer Chemother Pharmacol. 2006. PMID: 16133525 Clinical Trial.

6

Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.

Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, Gaiger A, Turetschek K, Jaeger U, Streubel B, Zielinski CC. Raderer M, et al. Among authors: bartsch r. J Clin Oncol. 2005 Nov 20;23(33):8442-6. doi: 10.1200/JCO.2004.00.8532. J Clin Oncol. 2005. PMID: 16293875 Clinical Trial.

7

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study.

Bartsch R, Wenzel C, Hussian D, Pluschnig U, Sevelda U, Koestler W, Altorjai G, Locker GJ, Mader R, Zielinski CC, Steger GG. Bartsch R, et al. BMC Cancer. 2006 Mar 15;6:63. doi: 10.1186/1471-2407-6-63. BMC Cancer. 2006. PMID: 16539726 Free PMC article. Clinical Trial.

8

Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.

Bartsch R, Fromm S, Rudas M, Wenzel C, Harbauer S, Roessler K, Kitz K, Steger GG, Weitmann HD, Poetter R, Zielinski CC, Dieckmann K. Bartsch R, et al. Radiother Oncol. 2006 Sep;80(3):313-7. doi: 10.1016/j.radonc.2006.08.001. Epub 2006 Sep 7. Radiother Oncol. 2006. PMID: 16959347

9

Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer.

Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Bachleitner-Hoffmann T, Locker GJ, Rudas M, Mader R, Zielinski CC, Steger GG. Bartsch R, et al. Breast Cancer Res Treat. 2007 May;102(3):375-81. doi: 10.1007/s10549-006-9342-5. Epub 2006 Sep 21. Breast Cancer Res Treat. 2007. PMID: 17028979 Clinical Trial.

10

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG. Wenzel C, et al. Among authors: bartsch r. Breast Cancer Res Treat. 2007 Jul;104(1):109-14. doi: 10.1007/s10549-006-9397-3. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters